1-42930036-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_006516.4(SLC2A1):c.517-1G>A variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_006516.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
GLUT1 deficiency syndrome 1, autosomal recessive Pathogenic:1
This sequence change affects an acceptor splice site in intron 4 of the SLC2A1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. A different variant affecting this nucleotide (c.517-G>C) has been reported de novo in an individual affected with intellectual disability and facial dysmorphism (PMID: 28554332). In addition a different variant affecting this canonical splice acceptor site (c.517-2A>G) has been reported in an individual affected with GLUT1-deficiency syndrome (PMID: 24080273). This suggests that this consensus splice is important for normal RNA splicing, and that other variants at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SLC2A1 are known to be pathogenic (PMID: 21832227, 26193382). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with SLC2A1-related disease. This variant is not present in population databases (ExAC no frequency). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at